A central hub for advancing kidney precision medicine
Official title: Central Hub for Kidney Precision Medicine
Funded at Icahn School of Medicine at Mount Sinai · NIH-11089214 · Data updated 2026-11-12
This study is all about bringing together doctors and researchers to work closely with patients to find better ways to understand and treat kidney diseases, making sure everyone’s safety and rights are respected along the way.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project start | July 1, 2024 |
| Project end | June 30, 2027 |
| Funding year | 2024 |
| Award (this year) | $4,127,999 |
| NIH project number | 7U24DK114886-08 |
| Project ID | NIH-11089214 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for participation include individuals with acute or chronic kidney conditions, particularly those experiencing renal failure.
✕Less likely to help
Patients with non-kidney-related health issues or those who do not meet the specific criteria for kidney conditions may not benefit from this research.
What this research studies
This research aims to establish a collaborative environment focused on improving kidney health through precision medicine. It will coordinate various research sites and engage with patients and the broader medical community to ensure ethical practices and participant safety. The project will facilitate the collection and sharing of high-quality data and biological samples, enhancing our understanding of kidney diseases. By fostering collaboration among researchers and clinicians, it seeks to drive significant advancements in the treatment and prevention of kidney-related conditions.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatments for kidney diseases.
How similar studies have gone: Previous research in kidney precision medicine has shown promising results, indicating that this approach could lead to significant advancements in treatment.
Where this research is happening
-
Icahn School of Medicine at Mount Sinai
New York, United States Active
Researchers
- Principal investigator: Himmelfarb, Jonathan — Icahn School of Medicine at Mount Sinai
- Study coordinator: Himmelfarb, Jonathan
Related research
Other NIH-funded projects on the same topics.
-
Improving Breast Cancer Guideline Adherence in Nigeria
Aimed at helping doctors in Nigeria follow international guideline-based breast cancer care to improve outcomes for women with breast cancer.
-
Genetically Validated PCOS Subtypes for Better Diagnosis and Risk Stratification
Aimed at women with polycystic ovary syndrome (PCOS), this project uses genetic data and patient characteristics to define distinct PCOS subtypes and improve how we diagnose and estimate risk.
-
Closed-loop control of interneuron timing to influence seizures and memory in epilepsy
A study tests a brain-quieting system that uses light to precisely time certain brain cells in epilepsy-prone mice to see if this can lessen seizures and improve memory.
-
Understanding why some brain regions and cells accumulate tau in Alzheimer’s and related diseases
Researchers are studying why certain brain areas and neuron types accumulate tau protein in Alzheimer’s and related conditions, and how this leads to brain changes and symptoms.
-
Improving blood flow after stroke by breaking down NETs
Aims to see if breaking down neutrophil extracellular traps (NETs) after an ischemic stroke can improve blood flow and reduce brain injury in patients.
-
Aging and brain injury connection: learning how late-life TBI relates to Alzheimer’s and related dementias
This grant looks at whether traumatic brain injuries in people 65 and older are linked to Alzheimer’s disease and related dementias, using a large, harmonized set of long-term aging studies.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.